El Centro de Investigación y Tratamiento del Cáncer y el Programa Disciplinario de Genética Humana del ICBM tienen el agrado de invitarlos al seminario:
Olivier Harismendy, M.S., Ph.D.
Department of Pediatrics
Moores Cancer Center
University of California, San Diego
Hosts: Dr. Katherine Marcelain and Dr. Ricardo Verdugo
M.S. in Process Engineering from ENSTA-ParisTech (France) and a joint M.S. in Microbiology from the Pasteur Institute and Paris 7 University. He obtained his PhD in Microbiology from the same university. He then joined Dr. Edelman’s Department of Neurobiology at The Scripps Research Institute (La Jolla, CA), where he developed ChIP-Seq approaches to study Neuron Restrictive Silencing Factor DNA binding in mouse developing brains. Under the mentorship of Dr Kelly Frazer, Dr. Harismendy went on to develop applications of high throughput sequencing for translational research: evaluating methods for targeted sequencing, exploring the role of regulatory variants in common diseases, and detecting and studying the role of somatic mutations in cancer. Since 2009 he leads the Oncogenomics laboratory at the Moores Cancer Center. His current research focuses on the development of assays and computational approaches to study tumor heterogeneity predict drug response and understand the contribution of gene regulatory elements in cancer etiology and progression. Strong of his experience in the molecular analysis of clinical samples and the interpretation of the data for cancer care, Dr Harismendy participates in the molecular tumor board and the protocol monitoring and review committee to review and advise on the design and execution of molecularly guided clinical trials.
Lunes 23 de Noviembre, 13:00-14:00
Serviremos pizzas a las 12:50
Sala Seminarios Danko Brncic, Bloque C
Programa de Genética Humana
Instituto de Ciencias Biomédica
Facultad de Medicina, Universidad de Chile